glp 1 drugs heart failure Impact of glp-1 receptor agonists on hospitalization for and all-cause death in patients with diabetes with and without heart failure: a real-world study | Clinical Research in Cardiology GLP-1 Receptor Agonists in Heart

Incidence and prevalence of lower extremity tendinopathy in a Dutch general practice population: a cross sectional study

YuanCWangCWangJKumarVAnwarFXiaoFet alInhibition on the growth of human MDA-MB-231 breast cancer cells in vitro and tumor growth in a mouse xenograft model by Se-containing polysaccharides from Pyracantha fortuneana

Pharmacodynamic studies were conducted only for albiglutide

The retatrutide onset timeline varies between individuals but most report clear effects by the 2-4 mg dose range

Meloni, A., Pistoia, L., Positano, V., De Luca, A., Martini, N., Spasiano, A., et al

The researchers found that taurine increased hydrogen sulfide in the blood vessels, which reduced blood pressure reactivity by inhibiting TRPM3 activation.[ref] Heart failure: In a small placebo-controlled clinical trial, taurine at 500 mg/3x/day for 2 weeks significantly improved physical function in heart failure patients.[ref]